IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ripps, H.
Right arrow Articles by Greenstein, V. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ripps, H.
Right arrow Articles by Greenstein, V. C.

Investigative Ophthalmology & Visual Science, Vol 25, 787-794, Copyright © 1984 by Association for Research in Vision and Ophthalmology


ARTICLES AND REPORTS

Functional abnormalities in vincristine-induced night blindness

H Ripps, RE Carr, IM Siegel and VC Greenstein

Various noninvasive test procedures were used to evaluate retinal function in a patient who had become night blind following vincristine chemotherapy. The results obtained were strikingly similar to those reported previously in subjects with recessively inherited stationary night blindness; the dark-adaptation curve was monophasic (ie, no evidence of a scotopic branch), rhodopsin kinetics were entirely normal, and spectral threshold data revealed the presence of residual rod-mediated vision. Also like the heritable condition, the b-wave of the ERG was depressed grossly despite normal a-wave potentials. These findings, and the fact that vincristine is known to disrupt the structural integrity of neuronal microtubules, suggest that the drug- induced defect involves the process of synaptic transmission between the photoreceptors and their second-order neurons.


This article has been cited by other articles:


Home page
Arch DermatolHome page
C. Jacobzone, C. Cochard-Marianowski, I. Kupfer, S. Bettembourg, Y. Dordain, L. Misery, B. Cochener, and B. Sassolas
Corticosteroid Treatment for Melanoma-Associated Retinopathy: Effect on Visual Acuity and Electrophysiologic Findings
Arch Dermatol, October 1, 2004; 140(10): 1258 - 1261.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
K. R. Alexander, C. S. Barnes, G. A. Fishman, J. Pokorny, and V. C. Smith
Contrast-Processing Deficits in Melanoma-Associated Retinopathy
Invest. Ophthalmol. Vis. Sci., January 1, 2004; 45(1): 305 - 310.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
K. R. Alexander, C. S. Barnes, G. A. Fishman, and A. H. Milam
Nature of the Cone ON-Pathway Dysfunction in Melanoma-Associated Retinopathy
Invest. Ophthalmol. Vis. Sci., April 1, 2002; 43(4): 1189 - 1197.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
W. W Dawson, B. L Jordan, R. D Marsh, K. Hazariwala, F. P Flowers, and T. Fang
Distant cancer effects on standardised testing of peripheral vision
Br. J. Ophthalmol., March 1, 2001; 85(3): 291 - 296.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1984 by the Association for Research in Vision and Ophthalmology